{"entity":{"type":"insider","cik":"0001623720","url":"/insider/0001623720","json_url":"/insider/0001623720.json","name":"Lim Richard J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":3,"first":"2016-06-29","last":"2019-07-01","span_basis":"filed_date"},"name_variants":[{"name":"Lim Richard J.","source":"filing","n_filings":3,"first_seen":"2016-06-29","last_seen":"2019-07-01"}],"transactions":[{"id":8288907,"accession":"0001179110-19-008266","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-19-008266","line_url":"/filing/0001179110-19-008266#line-3","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Paster Anne-Mari; Omega Fund V GP, L.P.; Omega Fund V GP Manager, Ltd.; Nessi Claudio; Stampacchia Otello; Omega Fund V, L.P.; Lim Richard J.","owner_display_name":"Paster Anne-Mari","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133333.0,"shares_display":"133,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1999995.0,"total_display":"1,999,995.00","total_whole":"1,999,995","shares_owned_after":2969582.0,"shares_owned_after_display":"2,969,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-01","scope":"insider"},{"id":6467241,"accession":"0000899243-18-020583","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-020583","line_url":"/filing/0000899243-18-020583#line-4","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Paster Anne-Mari; Omega Fund IV G.P. Manager, Ltd.; Omega Fund IV GP, L.P.; Stampacchia Otello; Lim Richard J.; Omega Fund IV, L.P.","owner_display_name":"Paster Anne-Mari","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":266667.0,"shares_display":"266,667","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4000005.0,"total_display":"4,000,005.00","total_whole":"4,000,005","shares_owned_after":266667.0,"shares_owned_after_display":"266,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-24","filed_date":"2018-07-25","scope":"insider"},{"id":2700639,"accession":"0001209191-16-130107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-130107","line_url":"/filing/0001209191-16-130107","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001623720","owner_name":"Lim Richard J.","owner_display_name":"Lim Richard J.","owner_url":"/insider/0001623720","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":461538.0,"shares_display":"461,538","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":5999994.0,"total_display":"5,999,994.00","total_whole":"5,999,994","shares_owned_after":779802.0,"shares_owned_after_display":"779,802","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-27","filed_date":"2016-06-29","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001679363","name":"Morphic Holding, Inc.","url":"/issuer/0001679363","role":"Ten percent owner","n_filings":1,"first_seen":"2019-07-01","last_seen":"2019-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001737953","name":"Replimune Group, Inc.","url":"/issuer/0001737953","role":"Ten percent owner","n_filings":1,"first_seen":"2018-07-25","last_seen":"2018-07-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001178711","name":"Paratek Pharmaceuticals, Inc.","url":"/issuer/0001178711","role":"Director","n_filings":1,"first_seen":"2016-06-29","last_seen":"2016-06-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001623720","retrieved_at":"2026-08-26T04:17:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}